CEACAM5 and breast carcinoma: The concentrations of CEA, CA 15–3 and TPA in serum of the patients with breast cancer (Table 1a) show that the sensitivity of urinary nucleosides in breast cancer patients was 76.9% (20 out of 26 patients) by using the Baye's technique.